Total lung capacity is predictive of disease severity and survival in systemic sclerosis: A longitudinal analysis in 2347 patients from the French National Cohort Study.

Background

Total lung capacity (TLC) is seldom assessed in the prediction of systemic sclerosis (SSc) disease severity.

Objective

To describe and analyse TLC in SSc.

Methods

We performed a retrospective multicentre study of SSc patients enrolled in the French national SSc cohort with at least one TLC assessment, described patients based on baseline TLC measurements, modelized TLC trajectories in SSc, and associated TLC measures with disease prognosis.

Results

Two thousand three hundred and forty-seven patients were included in the study. Baseline TLC was associated with disease severity and survival, as well as with the occurrence of interstitial lung disease (ILD), lung fibrosis (LF), and pulmonary arterial hypertension (PAH). Individual TLC trajectories varied among patients. Different models of TLC trajectories were assessed using latent process mixed models. The best model showed that the vast majority of SSc patients had stable TLC trajectories and clustered patients into three groups predictive of SSc survival, ILD, LF, and PAH. Lastly, a 10 % decrease of TLC was found to be predictive of a 5 % decrease in forced vital capacity (FVC), a 10 % decrease in DLCO, and consequently an earlier predictive marker of ILD and LF than FVC.

Limitations

Retrospective study.

Conclusion

TLC is predictive of disease severity and survival in SSc and SSc-ILD. This work suggests TLC as an earlier risk factor for ILD and LF than FVC in SSc.

Copyright © 2025 The Authors. Published by Elsevier Ltd.. All rights reserved.

Overview publication

TitleTotal lung capacity is predictive of disease severity and survival in systemic sclerosis: A longitudinal analysis in 2347 patients from the French National Cohort Study.
Date2025-03-01
Issue nameJournal of autoimmunity
Issue numberv152:103391
DOI10.1016/j.jaut.2025.103391
PubMed40037002
AuthorsChaigne B, Bense A, Aubourg F, Agard C, Allanore Y, Berezne A, Pugnet G, Hachulla E, Cottin V, Hot A, Dunogue B, Kanagaratnam A, Palat S, Lescoat A, Berthier S, Chatelus E, Rivière S, Launay D, Truchetet ME, Dinh-Xuan AT & Mouthon L
InfoFrench Systemic Sclerosis Network, Zahir Amoura, Avouac J, Aouba A, Balquet MH, Baudet A, Bienvenu B, Bonnotte B, de Boysson H, Bussone G, Couderc LJ, Decker P, Dhote R, Diot E, Fauchais AL, Goulenok T, Grange C, Harle JR, Imbert B, Kahn JE, Legendre P, Magy-Bertrand N, Maurier F, Lidove O, Mékinian A, Queyrel V, Smets P
KeywordsDisease severity, Forced vital capacity, Interstitial lung disease, Lung fibrosis, Prognosis, Survival, Systemic sclerosis, Total lung capacity
Read Read publication